RUVBL1 and non-small cell lung carcinoma: According to the established cut-off points, high cytoplasmic immunoreactivity of RUVBL1 was found in 14 (20.9%) NSCLC cases, whereas the remaining 53 (79.1%) demonstrated low or no expression.